1
|
Wittrant Y, Gorin Y, Woodruff K, Horn D,
Abboud HE, Mohan S and Abboud-Werner SL: High d(+)glucose
concentration inhibits RANKL-induced osteoclastogenesis. Bone.
42:1122–1130. 2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet. 1:R17–R29. 2006. View Article : Google Scholar
|
4
|
Huntzinger E and Izaurralde E: Gene
silencing by microRNAs: Contributions of translational repression
and mRNA decay. Nat Rev Genet. 12:99–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ciesla M, Skrzypek K, Kozakowska M, Loboda
A, Jozkowicz A and Dulak J: MicroRNAs as biomarkers of disease
onset. Anal Bioanal Chem. 401:2051–2061. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Song L and Tuan RS: MicroRNAs and cell
differentiation in mammalian development. Birth Defects Res C
Embryo Today. 78:140–149. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Davis BN and Hata A: Regulation of
MicroRNA Biogenesis: A miRiad of mechanisms. Cell Commun Signal.
7:182009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Stern-Ginossar N, Elefant N, Zimmermann A,
Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M,
Hahn G, et al: Host immune system gene targeting by a viral miRNA.
Science. 317:376–381. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Shu M, Zheng X, Wu S, Lu H, Leng T, Zhu W,
Zhou Y, Ou Y, Lin X, Lin Y, et al: Targeting oncogenic miR-335
inhibits growth and invasion of malignant astrocytoma cells. Mol
Cancer. 10:592011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhang J, Tu Q, Bonewald LF, He X, Stein G,
Lian J and Chen J: Effects of miR-335-5p in modulating osteogenic
differentiation by specifically downregulating Wnt antagonist DKK1.
J Bone Miner Res. 26:1953–1963. 2011. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Hu Z, Wang B, Cao X, Du T and Zhang S:
Prediction of micro-RNA related to change of mouse osteoblast
function under simulated microgravity with bioinformatics method.
Space Med Med Eng. 25:407–411. 2012.In Chinese.
|
12
|
Sato N, Yamabuki T, Takano A, Koinuma J,
Aragaki M, Masuda K, Ishikawa N, Kohno N, Ito H, Miyamoto M, et al:
Wnt inhibitor Dickkopf-1 as a target for passive cancer
immunotherapy. Cancer Res. 70:5326–5336. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
14
|
Jackuliak P and Payer J: Osteoporosis,
fractures, and diabetes. Int J Endocrinol. 2014:8206152014.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Marie PJ: Osteoblast dysfunctions in bone
diseases: From cellular and molecular mechanisms to therapeutic
strategies. Cell Mol Life Sci. 72:1347–1361. 2015. View Article : Google Scholar
|
16
|
Li H, Xie S, Liu M, Chen Z, Liu X, Wang L,
Li D and Zhou Y: The clinical significance of downregulation of
mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric
cancer tumorigenesis. Int J Oncol. 45:197–208. 2014.PubMed/NCBI
|
17
|
Cui XS, Sun SC, Kang YK and Kim NH:
Involvement of microRNA-335-5p in cytoskeleton dynamics in mouse
oocytes. Reprod Fertil Dev. 25:691–699. 2013. View Article : Google Scholar
|
18
|
Oger F, Gheeraert C, Mogilenko D, Benomar
Y, Molendi-Coste O, Bouchaert E, Caron S, Dombrowicz D, Pattou F,
Duez H, et al: Cell-specific dysregulation of microRNA expression
in obese white adipose tissue. J Clin Endocrinol Metab.
99:2821–2833. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhang J, Zhu X, Cui J, Chen P, Wang S and
Wang J: Differential expressions of microRNA between young and
senescent endothelial cells. Chin Med J. 92:2205–2209. 2012.In
Chinense.
|
20
|
Ertekin S, Yıldırım O, Dinç E, Ayaz L,
Fidanci SB and Tamer L: Evaluation of circulating miRNAs in wet
age-related macular degeneration. Mol Vis. 20:1057–1066.
2014.PubMed/NCBI
|
21
|
Wang XJ, Feng ZP, Deng HC, Jiang R and Du
J: Effect of AP-1 on apoptosis of MC3T3-E1 osteoblast induced by
high-glucose. Zhong Hua Gu Zhi Shu Song He Gu Kuang Yan Ji Bing Za
Zhi. 7:258–262. 2014.In Chinese.
|
22
|
Li J, Sarosi I, Cattley RC, Pretorius J,
Asuncion F, Grisanti M, Morony S, Adamu S, Geng Z, Qiu W, et al:
Dkk1-mediated inhibition of Wnt signaling in bone results in
osteopenia. Bone. 39:754–766. 2006. View Article : Google Scholar : PubMed/NCBI
|
23
|
Morvan F, Boulukos K, Clément-Lacroix P,
Roman Roman S, Suc-Royer I, Vayssière B, Ammann P, Martin P, Pinho
S, Pognonec P, et al: Deletion of a single allele of the Dkk1 gene
leads to an increase in bone formation and bone mass. J Bone Miner
Res. 21:934–945. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Qiang YW, Barlogie B, Rudikoff S and
Shaughnessy JD Jr: Dkk1-induced inhibition of Wnt signaling in
osteoblast differentiation is an underlying mechanism of bone loss
in multiple myeloma. Bone. 42:669–680. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wang LF, Bai D and Han XL: Progress in
Dickkopf-1-mediated bone metabolism. J Clin Rehabil Tissue Eng Res.
17:337–341. 2013.In Chinese.
|